Global In-Vitro Diagnostics Market Research Report 2023

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

Highlights

The global In-Vitro Diagnostics market was valued at US$ 67540 million in 2022 and is anticipated to reach US$ 87450 million by 2029, witnessing a CAGR of 4.4% during the forecast period 2023-2029.

The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 7% of the whole market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for In-Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Diagnostics.

The In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In-Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the In-Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Roche

Siemens

Abbott

Danaher

Thermo Fisher

BioMerieux

Bio-Rad

BD

JNJ

Sysmex

KHB

DaAn Gene

Leadman

BioSino

BSBE

Maccura

Tissue Diagnostics

Professional Diagnostic

Molecular Diagnostic

Diabetes Monitoring

Other

Diabetes

Infectious Diseases

Oncology

Cardiology

HIV

Other

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of In-Vitro Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global In-Vitro Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Tissue Diagnostics

1.2.3 Professional Diagnostic

1.2.4 Molecular Diagnostic

1.2.5 Diabetes Monitoring

1.2.6 Other

1.3 Market by Application

1.3.1 Global In-Vitro Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Diabetes

1.3.3 Infectious Diseases

1.3.4 Oncology

1.3.5 Cardiology

1.3.6 HIV

1.3.7 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global In-Vitro Diagnostics Market Perspective (2018-2029)

2.2 In-Vitro Diagnostics Growth Trends by Region

2.2.1 Global In-Vitro Diagnostics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 In-Vitro Diagnostics Historic Market Size by Region (2018-2023)

2.2.3 In-Vitro Diagnostics Forecasted Market Size by Region (2024-2029)

2.3 In-Vitro Diagnostics Market Dynamics

2.3.1 In-Vitro Diagnostics Industry Trends

2.3.2 In-Vitro Diagnostics Market Drivers

2.3.3 In-Vitro Diagnostics Market Challenges

2.3.4 In-Vitro Diagnostics Market Restraints

3.1 Global Top In-Vitro Diagnostics Players by Revenue

3.1.1 Global Top In-Vitro Diagnostics Players by Revenue (2018-2023)

3.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2018-2023)

3.2 Global In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by In-Vitro Diagnostics Revenue

3.4 Global In-Vitro Diagnostics Market Concentration Ratio

3.4.1 Global In-Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Diagnostics Revenue in 2022

3.5 In-Vitro Diagnostics Key Players Head office and Area Served

3.6 Key Players In-Vitro Diagnostics Product Solution and Service

3.7 Date of Enter into In-Vitro Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global In-Vitro Diagnostics Historic Market Size by Type (2018-2023)

4.2 Global In-Vitro Diagnostics Forecasted Market Size by Type (2024-2029)

5.1 Global In-Vitro Diagnostics Historic Market Size by Application (2018-2023)

5.2 Global In-Vitro Diagnostics Forecasted Market Size by Application (2024-2029)

6.1 North America In-Vitro Diagnostics Market Size (2018-2029)

6.2 North America In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America In-Vitro Diagnostics Market Size by Country (2018-2023)

6.4 North America In-Vitro Diagnostics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe In-Vitro Diagnostics Market Size (2018-2029)

7.2 Europe In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe In-Vitro Diagnostics Market Size by Country (2018-2023)

7.4 Europe In-Vitro Diagnostics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific In-Vitro Diagnostics Market Size (2018-2029)

8.2 Asia-Pacific In-Vitro Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific In-Vitro Diagnostics Market Size by Region (2018-2023)

8.4 Asia-Pacific In-Vitro Diagnostics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America In-Vitro Diagnostics Market Size (2018-2029)

9.2 Latin America In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America In-Vitro Diagnostics Market Size by Country (2018-2023)

9.4 Latin America In-Vitro Diagnostics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa In-Vitro Diagnostics Market Size (2018-2029)

10.2 Middle East & Africa In-Vitro Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2018-2023)

10.4 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche In-Vitro Diagnostics Introduction

11.1.4 Roche Revenue in In-Vitro Diagnostics Business (2018-2023)

11.1.5 Roche Recent Development

11.2 Siemens

11.2.1 Siemens Company Detail

11.2.2 Siemens Business Overview

11.2.3 Siemens In-Vitro Diagnostics Introduction

11.2.4 Siemens Revenue in In-Vitro Diagnostics Business (2018-2023)

11.2.5 Siemens Recent Development

11.3 Abbott

11.3.1 Abbott Company Detail

11.3.2 Abbott Business Overview

11.3.3 Abbott In-Vitro Diagnostics Introduction

11.3.4 Abbott Revenue in In-Vitro Diagnostics Business (2018-2023)

11.3.5 Abbott Recent Development

11.4 Danaher

11.4.1 Danaher Company Detail

11.4.2 Danaher Business Overview

11.4.3 Danaher In-Vitro Diagnostics Introduction

11.4.4 Danaher Revenue in In-Vitro Diagnostics Business (2018-2023)

11.4.5 Danaher Recent Development

11.5 Thermo Fisher

11.5.1 Thermo Fisher Company Detail

11.5.2 Thermo Fisher Business Overview

11.5.3 Thermo Fisher In-Vitro Diagnostics Introduction

11.5.4 Thermo Fisher Revenue in In-Vitro Diagnostics Business (2018-2023)

11.5.5 Thermo Fisher Recent Development

11.6 BioMerieux

11.6.1 BioMerieux Company Detail

11.6.2 BioMerieux Business Overview

11.6.3 BioMerieux In-Vitro Diagnostics Introduction

11.6.4 BioMerieux Revenue in In-Vitro Diagnostics Business (2018-2023)

11.6.5 BioMerieux Recent Development

11.7 Bio-Rad

11.7.1 Bio-Rad Company Detail

11.7.2 Bio-Rad Business Overview

11.7.3 Bio-Rad In-Vitro Diagnostics Introduction

11.7.4 Bio-Rad Revenue in In-Vitro Diagnostics Business (2018-2023)

11.7.5 Bio-Rad Recent Development

11.8 BD

11.8.1 BD Company Detail

11.8.2 BD Business Overview

11.8.3 BD In-Vitro Diagnostics Introduction

11.8.4 BD Revenue in In-Vitro Diagnostics Business (2018-2023)

11.8.5 BD Recent Development

11.9 JNJ

11.9.1 JNJ Company Detail

11.9.2 JNJ Business Overview

11.9.3 JNJ In-Vitro Diagnostics Introduction

11.9.4 JNJ Revenue in In-Vitro Diagnostics Business (2018-2023)

11.9.5 JNJ Recent Development

11.10 Sysmex

11.10.1 Sysmex Company Detail

11.10.2 Sysmex Business Overview

11.10.3 Sysmex In-Vitro Diagnostics Introduction

11.10.4 Sysmex Revenue in In-Vitro Diagnostics Business (2018-2023)

11.10.5 Sysmex Recent Development

11.11 KHB

11.11.1 KHB Company Detail

11.11.2 KHB Business Overview

11.11.3 KHB In-Vitro Diagnostics Introduction

11.11.4 KHB Revenue in In-Vitro Diagnostics Business (2018-2023)

11.11.5 KHB Recent Development

11.12 DaAn Gene

11.12.1 DaAn Gene Company Detail

11.12.2 DaAn Gene Business Overview

11.12.3 DaAn Gene In-Vitro Diagnostics Introduction

11.12.4 DaAn Gene Revenue in In-Vitro Diagnostics Business (2018-2023)

11.12.5 DaAn Gene Recent Development

11.13 Leadman

11.13.1 Leadman Company Detail

11.13.2 Leadman Business Overview

11.13.3 Leadman In-Vitro Diagnostics Introduction

11.13.4 Leadman Revenue in In-Vitro Diagnostics Business (2018-2023)

11.13.5 Leadman Recent Development

11.14 BioSino

11.14.1 BioSino Company Detail

11.14.2 BioSino Business Overview

11.14.3 BioSino In-Vitro Diagnostics Introduction

11.14.4 BioSino Revenue in In-Vitro Diagnostics Business (2018-2023)

11.14.5 BioSino Recent Development

11.15 BSBE

11.15.1 BSBE Company Detail

11.15.2 BSBE Business Overview

11.15.3 BSBE In-Vitro Diagnostics Introduction

11.15.4 BSBE Revenue in In-Vitro Diagnostics Business (2018-2023)

11.15.5 BSBE Recent Development

11.16 Maccura

11.16.1 Maccura Company Detail

11.16.2 Maccura Business Overview

11.16.3 Maccura In-Vitro Diagnostics Introduction

11.16.4 Maccura Revenue in In-Vitro Diagnostics Business (2018-2023)

11.16.5 Maccura Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Tissue Diagnostics

    Table 3. Key Players of Professional Diagnostic

    Table 4. Key Players of Molecular Diagnostic

    Table 5. Key Players of Diabetes Monitoring

    Table 6. Key Players of Other

    Table 7. Global In-Vitro Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global In-Vitro Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global In-Vitro Diagnostics Market Share by Region (2018-2023)

    Table 11. Global In-Vitro Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global In-Vitro Diagnostics Market Share by Region (2024-2029)

    Table 13. In-Vitro Diagnostics Market Trends

    Table 14. In-Vitro Diagnostics Market Drivers

    Table 15. In-Vitro Diagnostics Market Challenges

    Table 16. In-Vitro Diagnostics Market Restraints

    Table 17. Global In-Vitro Diagnostics Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global In-Vitro Diagnostics Market Share by Players (2018-2023)

    Table 19. Global Top In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2022)

    Table 20. Ranking of Global Top In-Vitro Diagnostics Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by In-Vitro Diagnostics Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players In-Vitro Diagnostics Product Solution and Service

    Table 24. Date of Enter into In-Vitro Diagnostics Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global In-Vitro Diagnostics Revenue Market Share by Type (2018-2023)

    Table 28. Global In-Vitro Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global In-Vitro Diagnostics Revenue Market Share by Type (2024-2029)

    Table 30. Global In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global In-Vitro Diagnostics Revenue Market Share by Application (2018-2023)

    Table 32. Global In-Vitro Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global In-Vitro Diagnostics Revenue Market Share by Application (2024-2029)

    Table 34. North America In-Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe In-Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific In-Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific In-Vitro Diagnostics Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America In-Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa In-Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Roche Company Detail

    Table 50. Roche Business Overview

    Table 51. Roche In-Vitro Diagnostics Product

    Table 52. Roche Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 53. Roche Recent Development

    Table 54. Siemens Company Detail

    Table 55. Siemens Business Overview

    Table 56. Siemens In-Vitro Diagnostics Product

    Table 57. Siemens Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 58. Siemens Recent Development

    Table 59. Abbott Company Detail

    Table 60. Abbott Business Overview

    Table 61. Abbott In-Vitro Diagnostics Product

    Table 62. Abbott Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 63. Abbott Recent Development

    Table 64. Danaher Company Detail

    Table 65. Danaher Business Overview

    Table 66. Danaher In-Vitro Diagnostics Product

    Table 67. Danaher Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 68. Danaher Recent Development

    Table 69. Thermo Fisher Company Detail

    Table 70. Thermo Fisher Business Overview

    Table 71. Thermo Fisher In-Vitro Diagnostics Product

    Table 72. Thermo Fisher Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 73. Thermo Fisher Recent Development

    Table 74. BioMerieux Company Detail

    Table 75. BioMerieux Business Overview

    Table 76. BioMerieux In-Vitro Diagnostics Product

    Table 77. BioMerieux Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 78. BioMerieux Recent Development

    Table 79. Bio-Rad Company Detail

    Table 80. Bio-Rad Business Overview

    Table 81. Bio-Rad In-Vitro Diagnostics Product

    Table 82. Bio-Rad Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 83. Bio-Rad Recent Development

    Table 84. BD Company Detail

    Table 85. BD Business Overview

    Table 86. BD In-Vitro Diagnostics Product

    Table 87. BD Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 88. BD Recent Development

    Table 89. JNJ Company Detail

    Table 90. JNJ Business Overview

    Table 91. JNJ In-Vitro Diagnostics Product

    Table 92. JNJ Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 93. JNJ Recent Development

    Table 94. Sysmex Company Detail

    Table 95. Sysmex Business Overview

    Table 96. Sysmex In-Vitro Diagnostics Product

    Table 97. Sysmex Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 98. Sysmex Recent Development

    Table 99. KHB Company Detail

    Table 100. KHB Business Overview

    Table 101. KHB In-Vitro Diagnostics Product

    Table 102. KHB Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 103. KHB Recent Development

    Table 104. DaAn Gene Company Detail

    Table 105. DaAn Gene Business Overview

    Table 106. DaAn Gene In-Vitro Diagnostics Product

    Table 107. DaAn Gene Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 108. DaAn Gene Recent Development

    Table 109. Leadman Company Detail

    Table 110. Leadman Business Overview

    Table 111. Leadman In-Vitro Diagnostics Product

    Table 112. Leadman Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 113. Leadman Recent Development

    Table 114. BioSino Company Detail

    Table 115. BioSino Business Overview

    Table 116. BioSino In-Vitro Diagnostics Product

    Table 117. BioSino Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 118. BioSino Recent Development

    Table 119. BSBE Company Detail

    Table 120. BSBE Business Overview

    Table 121. BSBE In-Vitro Diagnostics Product

    Table 122. BSBE Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 123. BSBE Recent Development

    Table 124. Maccura Company Detail

    Table 125. Maccura Business Overview

    Table 126. Maccura In-Vitro Diagnostics Product

    Table 127. Maccura Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 128. Maccura Recent Development

    Table 129. Research Programs/Design for This Report

    Table 130. Key Data Information from Secondary Sources

    Table 131. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global In-Vitro Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global In-Vitro Diagnostics Market Share by Type: 2022 VS 2029

    Figure 3. Tissue Diagnostics Features

    Figure 4. Professional Diagnostic Features

    Figure 5. Molecular Diagnostic Features

    Figure 6. Diabetes Monitoring Features

    Figure 7. Other Features

    Figure 8. Global In-Vitro Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global In-Vitro Diagnostics Market Share by Application: 2022 VS 2029

    Figure 10. Diabetes Case Studies

    Figure 11. Infectious Diseases Case Studies

    Figure 12. Oncology Case Studies

    Figure 13. Cardiology Case Studies

    Figure 14. HIV Case Studies

    Figure 15. Other Case Studies

    Figure 16. In-Vitro Diagnostics Report Years Considered

    Figure 17. Global In-Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 18. Global In-Vitro Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 19. Global In-Vitro Diagnostics Market Share by Region: 2022 VS 2029

    Figure 20. Global In-Vitro Diagnostics Market Share by Players in 2022

    Figure 21. Global Top In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2022)

    Figure 22. The Top 10 and 5 Players Market Share by In-Vitro Diagnostics Revenue in 2022

    Figure 23. North America In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. North America In-Vitro Diagnostics Market Share by Country (2018-2029)

    Figure 25. United States In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Canada In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Europe In-Vitro Diagnostics Market Share by Country (2018-2029)

    Figure 29. Germany In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. France In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. U.K. In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Italy In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Russia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Nordic Countries In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Asia-Pacific In-Vitro Diagnostics Market Share by Region (2018-2029)

    Figure 37. China In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Japan In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. South Korea In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Southeast Asia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. India In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Australia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Latin America In-Vitro Diagnostics Market Share by Country (2018-2029)

    Figure 45. Mexico In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Brazil In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa In-Vitro Diagnostics Market Share by Country (2018-2029)

    Figure 49. Turkey In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Saudi Arabia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 51. Roche Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 52. Siemens Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 53. Abbott Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 54. Danaher Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 55. Thermo Fisher Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 56. BioMerieux Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 57. Bio-Rad Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 58. BD Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 59. JNJ Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 60. Sysmex Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 61. KHB Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 62. DaAn Gene Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 63. Leadman Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 64. BioSino Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 65. BSBE Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 66. Maccura Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 67. Bottom-up and Top-down Approaches for This Report

    Figure 68. Data Triangulation

    Figure 69. Key Executives Interviewed